News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Business
Accium BioSciences, Inc. Takes $3 Million Series A
January 6, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Accium BioSciences, a provider of bioanalytical services with a focus on early-stage drug development, has raised $3 million in a Series A round.
Twitter
LinkedIn
Facebook
Email
Print
Startups
MORE ON THIS TOPIC
Mergers & acquisitions
BioNTech Swallows Vaccine Rival CureVac in $1.25B All-Stock Acquisition
June 12, 2025
·
3 min read
·
Tristan Manalac
Layoffs
Genentech Lays Off 143 Employees in South San Francisco Reshuffle
June 11, 2025
·
1 min read
·
Dan Samorodnitsky
Deals
BMS Expands Radiopharma Presence With $1.35B Biobucks Deal for Philochem
June 11, 2025
·
2 min read
·
Tristan Manalac
Funding
SpliceBio Nabs $135 Million Series B To Advance Protein Splicing Medicines
June 11, 2025
·
2 min read
·
Dan Samorodnitsky
